Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis

ABSTRACT: The ATP synthase is a multicomponent enzyme that is largely conserved across the kingdoms of life. In many species the ATP synthase is central in the synthesis of ATP by using the electrochemical proton gradient generated via the electron transport chain. Bacteria inhabit very diverse ecol...

Full description

Bibliographic Details
Main Authors: Martin Vestergaard, Dirk Bald, Hanne Ingmer
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716522000303
_version_ 1828810488761286656
author Martin Vestergaard
Dirk Bald
Hanne Ingmer
author_facet Martin Vestergaard
Dirk Bald
Hanne Ingmer
author_sort Martin Vestergaard
collection DOAJ
description ABSTRACT: The ATP synthase is a multicomponent enzyme that is largely conserved across the kingdoms of life. In many species the ATP synthase is central in the synthesis of ATP by using the electrochemical proton gradient generated via the electron transport chain. Bacteria inhabit very diverse ecological niches; hence their metabolism to extract nutrients and generation of ATP varies from species to species. Some species are obligate aerobes (e.g., Mycobacterium tuberculosis), relying on oxidative phosphorylation for ATP synthesis, whereas others are strict anaerobes (e.g., Clostridioides difficile) relying primarily on substrate-level phosphorylation using various fermentative pathways. Yet other species, such as Staphylococcus aureus and Escherichia coli are facultative anaerobes and can convert energy via both respiratory and fermentative pathways. The metabolic propensity and growth conditions experienced by bacterial species have a great impact on the necessity of a functional ATP synthase for viability.The ATP synthase has been validated as a druggable target with the approval of the ATP synthase inhibitor bedaquiline for treatment of M. tuberculosis, an organism in which the ATP synthase is essential for growth. Currently, no ATP synthase inhibitors are in clinical use against non-mycobacterial pathogens.In this review, the physiological functions of the ATP synthase in various bacterial pathogens are discussed in relation to the metabolic pathways utilized for providing energy. The ATP synthase is essential in important pathogenic species that are obligate aerobes, obligate anaerobes and aerotolerant anaerobes, whereas it is dispensable for growth in most facultative anaerobic pathogens. Interference with the ATP synthase in facultative anaerobes has physiological consequences, such as membrane hyperpolarization, which can be exploited for combination therapies.Collectively, the available data indicate that the ATP synthase is an interesting target for development of new antimicrobials beyond M. tuberculosis.
first_indexed 2024-12-12T09:12:39Z
format Article
id doaj.art-7a0c9cc51a714ba9817513dcd9af94ae
institution Directory Open Access Journal
issn 2213-7165
language English
last_indexed 2024-12-12T09:12:39Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Journal of Global Antimicrobial Resistance
spelling doaj.art-7a0c9cc51a714ba9817513dcd9af94ae2022-12-22T00:29:28ZengElsevierJournal of Global Antimicrobial Resistance2213-71652022-06-01292941Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosisMartin Vestergaard0Dirk Bald1Hanne Ingmer2Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, DenmarkDepartment of Molecular Cell Biology, AIMMS, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark; Corresponding author. Mailing address: Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Stigbøjlen 4, DK-1870 Frederiksberg C, Denmark.ABSTRACT: The ATP synthase is a multicomponent enzyme that is largely conserved across the kingdoms of life. In many species the ATP synthase is central in the synthesis of ATP by using the electrochemical proton gradient generated via the electron transport chain. Bacteria inhabit very diverse ecological niches; hence their metabolism to extract nutrients and generation of ATP varies from species to species. Some species are obligate aerobes (e.g., Mycobacterium tuberculosis), relying on oxidative phosphorylation for ATP synthesis, whereas others are strict anaerobes (e.g., Clostridioides difficile) relying primarily on substrate-level phosphorylation using various fermentative pathways. Yet other species, such as Staphylococcus aureus and Escherichia coli are facultative anaerobes and can convert energy via both respiratory and fermentative pathways. The metabolic propensity and growth conditions experienced by bacterial species have a great impact on the necessity of a functional ATP synthase for viability.The ATP synthase has been validated as a druggable target with the approval of the ATP synthase inhibitor bedaquiline for treatment of M. tuberculosis, an organism in which the ATP synthase is essential for growth. Currently, no ATP synthase inhibitors are in clinical use against non-mycobacterial pathogens.In this review, the physiological functions of the ATP synthase in various bacterial pathogens are discussed in relation to the metabolic pathways utilized for providing energy. The ATP synthase is essential in important pathogenic species that are obligate aerobes, obligate anaerobes and aerotolerant anaerobes, whereas it is dispensable for growth in most facultative anaerobic pathogens. Interference with the ATP synthase in facultative anaerobes has physiological consequences, such as membrane hyperpolarization, which can be exploited for combination therapies.Collectively, the available data indicate that the ATP synthase is an interesting target for development of new antimicrobials beyond M. tuberculosis.http://www.sciencedirect.com/science/article/pii/S2213716522000303ATP synthaseMetabolismInhibitorsMembrane polarizationAntibiotic adjuvant target
spellingShingle Martin Vestergaard
Dirk Bald
Hanne Ingmer
Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis
Journal of Global Antimicrobial Resistance
ATP synthase
Metabolism
Inhibitors
Membrane polarization
Antibiotic adjuvant target
title Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis
title_full Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis
title_fullStr Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis
title_full_unstemmed Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis
title_short Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis
title_sort targeting the atp synthase in bacterial and fungal pathogens beyond mycobacterium tuberculosis
topic ATP synthase
Metabolism
Inhibitors
Membrane polarization
Antibiotic adjuvant target
url http://www.sciencedirect.com/science/article/pii/S2213716522000303
work_keys_str_mv AT martinvestergaard targetingtheatpsynthaseinbacterialandfungalpathogensbeyondmycobacteriumtuberculosis
AT dirkbald targetingtheatpsynthaseinbacterialandfungalpathogensbeyondmycobacteriumtuberculosis
AT hanneingmer targetingtheatpsynthaseinbacterialandfungalpathogensbeyondmycobacteriumtuberculosis